MonitorPlan n/a · Option n/aWatch before adding
HDFC Equity Opp Fund - II - 1100D June 2017 (1)
- NAV
- 13.298
- 20 Jan 2022
- 1Y
- +23.6%
- Trailing CAGR
- AUM
- ₹30.59 Cr
- 31 Mar 2022
- Volatility
- High
- 20.0% annualized
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 20 Jan 2022
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · Long-term category-relative performance remains stronger than the most recent rolling 1-year windows, which have deteriorated across multiple periods.
Fits if · AUM fell by 30% or more versus the prior observation.
Prefer peers if · Prefer Kotak India Fund Series 4 if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Pass
9.3 years of path to read.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
n/a
TER not on file yet.
Drawdown vs peers
Pass
Peak-to-trough -33.6%. Ask whether you can hold through a similar fall.
Vs category
Fail
0% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
n/a
Manager not listed.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
n/a
Holdings weights not on file for this scheme yet.
Browse category
Same-category peers are preloaded into compare when available.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+23.6%
- 3Y+11.1%
- 5Yn/a
- 10Yn/a
- SI+6.5%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+24.3%
- 3Y+19.0%
- 5Yn/a
- 10Yn/a
- Since inception
- +6.5%
- Calendar-day CAGR
- Excess 1Y
- +15.7%
- Category median, same plan and option
- 3Y win rate
- 0%
- Windows beating the median
- 3Y percentile
- 51
- Vs comparable share classes
- SIP 3Y XIRR
- +19.0%
- Simulated monthly SIP
- Worst rolling 3Y
- -6.3%
- 377 daily-ending windows
- Median rolling 3Y
- +4.2%
- Calendar-day CAGR
- Positive rolling 5Y
- n/a
- 0 daily-ending windows
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -33.6%
- Worst peak-to-trough
- Current
- -2.5%
- Below last peak
- Current spell
- 3 days
- Days below latest peak
- Time below peak
- +93%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 30 days
- 30 recovered episodes
- Longest recovery
- 333 days
- Trough to prior peak
27 May 2019 – 11 Jan 2021
Trough 19 Mar 2020 · recovered in 298 days
-33.6%
23 Jan 2018 – 27 May 2019
Trough 28 Jun 2018 · recovered in 333 days
-13.3%
18 Oct 2021 – 17 Jan 2022
Trough 20 Dec 2021 · recovered in 28 days
-7.8%
14 Jan 2021 – 2 Feb 2021
Trough 29 Jan 2021 · recovered in 4 days
-6.2%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
51
Vs category
100
Consistency
19
Risk-adjusted
31
Drawdown
16
Mean
43
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Monitor
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
- Long-term category-relative performance remains stronger than the most recent rolling 1-year windows, which have deteriorated across multiple periods.
- AUM fell by 30% or more versus the prior observation.
Supporting reads
No supporting reads in the current evidence set.
What changed
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
20 Jan 2022
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Kotak India Fund Series 4
Kotak Mahindra Mutual Fund
- 1Y
- +50.3%
- 3Y
- +25.4%
- Vol
- 17.0%
- Max DD
- -29.1%
- Sharpe
- 0.87
- 3Y win
- +100%
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
- Higher trailing returns
Kotak India Fund Series 7
Kotak Mahindra Mutual Fund
- 1Y
- +38.2%
- 3Y
- n/a
- Vol
- 19.7%
- Max DD
- -30.0%
- Sharpe
- 0.51
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
- Higher trailing returns
Reliance Capital Builder Fund II - Series B
Nippon India Mutual Fund
- 1Y
- +2.6%
- 3Y
- +18.1%
- Vol
- 19.2%
- Max DD
- -33.5%
- Sharpe
- 0.18
- 3Y win
- +100%
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
- Higher trailing returns
Reliance Capital Builder Fund- Series A
Nippon India Mutual Fund
- 1Y
- +31.3%
- 3Y
- n/a
- Vol
- 18.4%
- Max DD
- -23.0%
- Sharpe
- 0.81
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
- Higher trailing returns
Reliance Close Ended Equity Fund II- Series A
Nippon India Mutual Fund
- 1Y
- +1.7%
- 3Y
- +13.7%
- Vol
- 13.8%
- Max DD
- -17.4%
- Sharpe
- 0.58
- 3Y win
- +100%
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
- Higher trailing returns